State of Alaska Department of Revenue grew its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.0% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 59,456 shares of the medical research company’s stock after buying an additional 562 shares during the period. State of Alaska Department of Revenue’s holdings in Thermo Fisher Scientific were worth $13,303,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in TMO. Paloma Partners Management Co raised its position in Thermo Fisher Scientific by 1,294.5% in the second quarter. Paloma Partners Management Co now owns 2,036 shares of the medical research company’s stock worth $421,000 after purchasing an additional 1,890 shares in the last quarter. Tower Research Capital LLC TRC acquired a new position in Thermo Fisher Scientific in the second quarter worth about $1,854,000. Colony Group LLC raised its position in Thermo Fisher Scientific by 26.6% in the second quarter. Colony Group LLC now owns 4,442 shares of the medical research company’s stock worth $920,000 after purchasing an additional 933 shares in the last quarter. Select Equity Group L.P. raised its position in Thermo Fisher Scientific by 2.2% in the second quarter. Select Equity Group L.P. now owns 1,144,832 shares of the medical research company’s stock worth $237,140,000 after purchasing an additional 24,907 shares in the last quarter. Finally, Orbimed Advisors LLC raised its position in Thermo Fisher Scientific by 49.8% in the second quarter. Orbimed Advisors LLC now owns 583,500 shares of the medical research company’s stock worth $120,866,000 after purchasing an additional 194,100 shares in the last quarter. 86.92% of the stock is owned by institutional investors and hedge funds.

In other news, Director Tyler Jacks sold 1,100 shares of the stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $251.98, for a total transaction of $277,178.00. Following the sale, the director now directly owns 5,879 shares of the company’s stock, valued at $1,481,390.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stephen Williamson sold 9,500 shares of the stock in a transaction that occurred on Friday, December 7th. The shares were sold at an average price of $241.45, for a total transaction of $2,293,775.00. Following the sale, the chief financial officer now directly owns 44,124 shares in the company, valued at $10,653,739.80. The disclosure for this sale can be found here. Insiders have sold 32,607 shares of company stock worth $7,972,085 over the last ninety days. Insiders own 0.49% of the company’s stock.

Shares of Thermo Fisher Scientific stock opened at $238.86 on Friday. The company has a current ratio of 1.84, a quick ratio of 1.27 and a debt-to-equity ratio of 0.66. The stock has a market cap of $89.28 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.45 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 1-year low of $194.51 and a 1-year high of $253.91.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 24th. The medical research company reported $2.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.55 by $0.07. The firm had revenue of $5.92 billion for the quarter, compared to analysts’ expectations of $5.70 billion. Thermo Fisher Scientific had a net margin of 10.75% and a return on equity of 16.49%. The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.31 earnings per share. As a group, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 11.05 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Shareholders of record on Monday, December 17th will be paid a dividend of $0.17 per share. The ex-dividend date is Friday, December 14th. This represents a $0.68 annualized dividend and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is 7.17%.

Several research firms recently issued reports on TMO. UBS Group began coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, October 9th. They issued a “buy” rating and a $295.00 price target for the company. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Thursday, December 6th. Goldman Sachs Group cut shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Monday, September 17th. Morgan Stanley upped their price objective on shares of Thermo Fisher Scientific from $254.00 to $260.00 and gave the stock an “overweight” rating in a research note on Thursday, October 25th. Finally, Robert W. Baird upped their price objective on shares of Thermo Fisher Scientific from $256.00 to $264.00 and gave the stock an “outperform” rating in a research note on Thursday, October 25th. Three research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $271.10.

WARNING: This article was originally published by Daily Political and is owned by of Daily Political. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2019/01/11/thermo-fisher-scientific-inc-tmo-shares-bought-by-state-of-alaska-department-of-revenue.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Risk Tolerance and Your Investment Decisions

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.